Myrna C. B. Godoy

Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial

Tina Cascone, William N. William, Annikka Weissferdt et al. · Nature Medicine · 2021 · 604 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Augmenting the National Institutes of Health Chest Radiograph Dataset with Expert Annotations of Possible Pneumonia

George Shih, Carol C. Wu, Safwan S. Halabi et al. · Radiology Artificial Intelligence · 2019 · 330 citations · Full text

Medicine, Biomedical Informatics, Radiology +15

The IASLC Lung Cancer Staging Project: Background Data and Proposed Criteria to Distinguish Separate Primary Lung Cancers from Metastatic Foci in Patients with Two Lung Tumors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer

Frank C. Detterbeck, Wilbur A. Franklin, Andrew G. Nicholson et al. · Journal of Thoracic Oncology · 2016 · 266 citations · Full text

Medicine, Oncology, Pathology +13

Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial

Tina Cascone, Cheuk Hong Leung, Annikka Weissferdt et al. · Nature Medicine · 2023 · 206 citations · Full text

Medicine, Oncology, Pharmacology +17

The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Application of TNM Staging Rules to Lung Cancer Presenting as Multiple Nodules with Ground Glass or Lepidic Features or a Pneumonic Type of Involvement in the Forthcoming Eighth Edition of the TNM Classification

Frank Detterbeck, Edith M. Marom, Douglas A. Arenberg et al. · Journal of Thoracic Oncology · 2016 · 200 citations · Full text

Medicine, Oncology, Pathology +17